Between Abstinence-only Education and Drug Patents...We can make $15billion seem like nothing!
From: The'>http://www.developmentex.com/briefing/110404.html"> The Global Development Briefing:
UNITED STATES: The U.S. government is paying twice as much for many of the drugs in its global AIDS program as other international aid organizations are, because the Bush administration won't buy cheaper versions made in India, congressional investigators found, The Wall Street Journal reports. A draft report by the Government Accountability Office, the first independent comparison of the AIDS-drug prices, shows that the lowest price available to the US for one common AIDS-drug regimen, stavudine, lamivudine and nevirapine, is $562 per person annually. That compares with $215 available to international AIDS groups not bound by US restrictions. The stark price differences mean that President Bush's five-year, $15 billion global AIDS fund won't go as far as it might have. Mark Dybul, Chief Medical Officer for the Office of the US Global AIDS Coordinator, acknowledges that prices for Indian-made three-in-one AIDS pills are lower than the drugs the US is buying. The combination pills, made by Indian companies Ranbaxy Laboratories Ltd. and Cipla Ltd., are cheaper and cut the number of pills patients must take daily from six to two. The big US drugmakers don't produce the AIDS combination drugs; separately they make the individual components that are patented in the U.S.